SGEN - Seattle Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201712/31/201612/31/201512/31/2014
Net Income-125,530-140,111-120,486-76,141
Operating Activities, Cash Flows Provided By or Used In
Depreciation24,26918,03414,50512,490
Adjustments To Net Income-2,98956,33543,76139,735
Changes In Accounts Receivables-22,846-8,998-13,682-9,740
Changes In Liabilities2,220-6,692-41,837-4,733
Changes In Inventories8,146-11,161-13,512-16,378
Changes In Other Operating Activities-2,170-4,378-1,952-5,232
Total Cash Flow From Operating Activities-118,900-96,971-133,203-59,999
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-28,722-27,835-13,392-17,176
Investments200,24096,028-362,45853,798
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities129,86168,193-375,85036,622
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings----
Other Cash Flows from Financing Activities----
Total Cash Flows From Financing Activities41,31135,196554,38116,188
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents52,2726,41845,328-7,189